NASDAQ: SPPI CLASS ACTION NOTICE: Berger Montague Encourages Spectrum Pharmaceuticals (NASDAQ: SPPI) Investors to Inquire About a Securities Fraud Class Action - Candlesense
SPPI Lawsuits

NASDAQ: SPPI CLASS ACTION NOTICE: Berger Montague Encourages Spectrum Pharmaceuticals (NASDAQ: SPPI) Investors to Inquire About a Securities Fraud Class Action

PHILADELPHIA, Aug. 19, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC is investigating securities fraud claims against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) ("Spectrum" or the "Company") on behalf of investors who purchased or otherwise acquired common...

Related Questions

How likely is a material negative impact on SPPI's share price due to this lawsuit? What is the estimated timeline for resolution or settlement of the securities fraud claim? Could this class action trigger further regulatory scrutiny or affect the company's financing and pipeline activities?
Find similar articles on Candlesense prnewswire